Skip to main content

BMO Capital Keeps Their Buy Rating on Ingevity (NGVT)

Tipranks - Tipranks - Wed Oct 1, 2025

In a report released today, John McNulty from BMO Capital maintained a Buy rating on Ingevity, with a price target of $69.00. The company’s shares opened today at $54.68.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, McNulty is a 3-star analyst with an average return of 2.5% and a 54.08% success rate. McNulty covers the Basic Materials sector, focusing on stocks such as DuPont de Nemours, PPG Industries, and Ingevity.

Ingevity has an analyst consensus of Moderate Buy, with a price target consensus of $60.67.

See Insiders’ Hot Stocks on TipRanks >>

Based on Ingevity’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $365.1 million and a GAAP net loss of $146.5 million. In comparison, last year the company earned a revenue of $390.6 million and had a GAAP net loss of $283.7 million

Read More on NGVT:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).